Essays on information asymmetry, disclosures and the financing of R&D. The case of the biotechnology industry
Explore this paper's citation graph
- Published
- 2013-11-22
- Cited by
- 0
- References
- 94
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:55772203
References
- Seasoned Equity Issues and Ownership Concentration in a Closely Held Market: An Alignment Effect Test Free from the Unobserved Firm Heterogeneity Problem
- Econometric Models of Probabilistic Choice
- Key Disclosure Issues for Life Sciences Companies: FDA Product Approval, Clinical Test Results, and Government Inspections
- The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs
- Stock return variances: The arrival of information and the reaction of traders
- Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
- Investor sentiment in the stock market
- Equity ownership concentration and firm value: Evidence from private equity financings
- Seasoned Equity Offerings: An Empirical Investigation
- Management Ownership and Market Valuation: An Empirical Analysis
- Information asymmetry, adverse selection and joint-ventures* Theory and evidence
- Impact of mergers & acquisitions on research productivity within the pharmaceutical industry
- Pre-Tender Offer Share Acquisition Strategy in Takeovers
- When do firms learn from their acquisition experience? Evidence from 1990 to 1995
- Can a Previous Alliance Between an Acquirer and a Target Affect Acquisition Performance?
- The Post-Merger Performance of Acquiring Firms: A Re-examination of an Anomaly
- The overall gains from large bank mergers
- Proactive Versus Reactive M&A Activities in the Biotechnology Industry
- Corporate Dividends and Seasoned Equity Issues: An Empirical Investigation
- Why do Firms Issue Equity?
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.